Mark Byers is currently the Sr. Director of CMC Asset Leadership at Biogen, having previously held the positions of Sr. Director in ADPM Gene Therapy and CMC Director of Technical Development at the same company. Prior to their tenure at Biogen, Mark was a Principal Engineer at Amgen, Inc. from 1995 to 2007 and served as a Lab Supervisor at Synergen from 1991 to 1994. Mark's extensive experience in the biotechnology field highlights their leadership and technical expertise in drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices